Hb Wealth Management, LLC Dexcom Inc Transaction History

Hb Wealth Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$110.31 - $140.45 $44,124 - $56,179	400 Added 8.07%	5,355 $607,000
Q1 2024 Apr 30, 2024	SELL	$114.22 - $140.1 $5,254 - $6,444	-46 Reduced 0.92%	4,955 $687,000
Q4 2023 Jan 16, 2024	BUY	$75.49 - $124.16 $149,470 - $245,836	1,980 Added 65.54%	5,001 $620,000
Q3 2023 Oct 13, 2023	SELL	$86.06 - $137.93 $51,636 - $82,758	-600 Reduced 16.57%	3,021 $281,000
Q2 2023 Jul 13, 2023	BUY	$112.47 - $130.98 $42,626 - $49,641	379 Added 11.69%	3,621 $465,000
Q1 2023 Apr 13, 2023	SELL	$104.0 - $122.92 $936 - $1,106	-9 Reduced 0.28%	3,242 $376,000
Q4 2022 Jan 20, 2023	BUY	$84.98 - $122.67 $34,161 - $49,313	402 Added 14.11%	3,251 $0
Q3 2022 Oct 19, 2022	BUY	$76.35 - $94.18 $217,521 - $268,318	2,849 New	2,849 $229,000
Q2 2022 Jul 15, 2022	SELL	$67.99 - $132.89 $35,218 - $68,837	-518 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $48,733 - $67,443	518 New	518 $265,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Hb Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hb Wealth Management, LLC with notifications on news.